TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARAY

Accuray Incorporated

Healthcare · Medical Devices

0.2336$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Accuray Incorporated (ARAY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.2% of the shares are freely tradable; institutional investors hold 69.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 69.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 95.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 119Mio.

Largest Shareholders

Institutions

Institutions ARAY
Name Stake (%) Shares Change (%) Date
TCW Group Inc 12.95 15,467,952 +0.0 03/31/2026
BlackRock Inc 7.08 8,458,409 -1.0 03/31/2026
Neuberger Berman Group LLC 4.90 5,855,064 +17.9 03/31/2026
Armistice Capital, LLC 4.72 5,636,000 +25.2 03/31/2026
Weber Capital Management LLC 4.13 4,932,706 -2.4 06/30/2026
Vanguard Capital Management, LLC 3.71 4,430,392 +0.0 03/31/2026
Geode Capital Management, LLC 1.99 2,380,839 -3.9 03/31/2026
Mackenzie Investments 1.96 2,346,360 +22.3 03/31/2026

Funds

Funds ARAY
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.61 3,122,473 +0.0 07/31/2026
Acuitas US Microcap Strategy 2.00 2,392,126 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?